Cargando…

The Slough of Cicadidae Periostracum Ameliorated Lichenification by Inhibiting Interleukin (IL)-22/Janus Kinase (JAK) 1/Signal Transducer and Activator of Transcription (STAT) 3 Pathway in Atopic Dermatitis

It is known that animal-origin medicine could be one of effective treatment to remedy atopic dermatitis (AD) by controlling the cytokines. Cicadidae Periostracum (CP), the slough of Cryptotympana pustulata, has been frequently used for treating AD and skin affliction in traditional Korean Medicine....

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Ganghye, Kwon, Namgyu, Kim, Mi Hye, Yang, Woong Mo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Food Science of Animal Resources 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493567/ https://www.ncbi.nlm.nih.gov/pubmed/37701738 http://dx.doi.org/10.5851/kosfa.2023.e40

Ejemplares similares

Cicadidae Periostracum Attenuates Atopic Dermatitis Symptoms and Pathology via the Regulation of NLRP3 Inflammasome Activation
por: Park, Gunhyuk, et al.
Publicado: (2021)

Effectiveness of Keishibukuryogan on Chronic-Stage Lichenification Associated with Atopic Dermatitis
por: Mizawa, Megumi, et al.
Publicado: (2012)

Derma-Hc, a New Developed Herbal Formula, Ameliorates Cutaneous Lichenification in Atopic Dermatitis
por: Nam, Yeon Kyung, et al.
Publicado: (2021)

Cicadidae Periostracum, the Cast-Off Skin of Cicada, Protects Dopaminergic Neurons in a Model of Parkinson's Disease
por: Lim, Hye-Sun, et al.
Publicado: (2019)

Generalized lichenification sparing the nose
por: Kura, Mahendra M., et al.
Publicado: (2022)

Interferon-γ induces interleukin-6 production by neutrophils via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway
por: Yoshida, Shuhei, et al.
Publicado: (2021)

Erythroderma and Chronic Lichenification Due to Metformin
por: Díaz, Javier Moreno, et al.
Publicado: (2019)

Anti-Inflammatory Effects of Cicadidae Periostracum Extract and Oleic Acid through Inhibiting Inflammatory Chemokines Using PCR Arrays in LPS-Induced Lung inflammation In Vitro
por: Hong, Jung-Hee, et al.
Publicado: (2022)

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
por: Huang, I-Hsin, et al.
Publicado: (2022)

Janus kinase inhibitors for the therapy of atopic dermatitis
por: Traidl, Stephan, et al.
Publicado: (2021)

JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
por: Szalus, Krzysztof, et al.
Publicado: (2020)

The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis
por: Bao, Lei, et al.
Publicado: (2013)

Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
por: Kopalli, Spandana Rajendra, et al.
Publicado: (2022)

Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
por: Singh, Rhea, et al.
Publicado: (2020)

The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
por: Tsiogka, Aikaterini, et al.
Publicado: (2022)

The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway
por: Han, Xianwei, et al.
Publicado: (2023)

Interleukin-6 Promotes Proliferation but Inhibits Tenogenic Differentiation via the Janus Kinase/Signal Transducers and Activators of Transcription 3 (JAK/STAT3) Pathway in Tendon-Derived Stem Cells
por: Chen, Siwei, et al.
Publicado: (2018)

Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
por: Montilla, Ana M., et al.
Publicado: (2019)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
por: Nogueira, Miguel, et al.
Publicado: (2021)

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023)

A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
por: Tampa, Mircea, et al.
Publicado: (2023)

Early Stage Biomineralization in the Periostracum of the ‘Living Fossil’ Bivalve Neotrigonia
por: Checa, Antonio G., et al.
Publicado: (2014)

Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
por: Panipinto, Paul M., et al.
Publicado: (2021)

Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo
por: Wu, Qing, et al.
Publicado: (2022)

Banhahubak-Tang Tablet, a Standardized Medicine Attenuates Allergic Asthma via Inhibition of Janus Kinase 1 (JAK1)/ Signal Transducer and Activator of Transcription 6 (STAT6) Signal Pathway
por: Nam, Yeon Kyung, et al.
Publicado: (2020)

Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
por: Lytvyn, Yuliya, et al.
Publicado: (2023)

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
por: Le, Michelle, et al.
Publicado: (2021)

A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis
por: Lee, Sang-Doo, et al.
Publicado: (2022)

Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
por: Alves, Carlos, et al.
Publicado: (2023)

Baicalin Ameliorates Collagen-Induced Arthritis Through the Suppression of Janus Kinase 1 (JAK1)/Signal Transducer and Activator of Transcription 3 (STAT3) Signaling in Mice
por: Wang, Chunxiao, et al.
Publicado: (2018)

Esculetin Inhibits Proliferation, Invasion, and Migration of Laryngeal Cancer In Vitro and In Vivo by Inhibiting Janus Kinas (JAK)-Signal Transducer and Activator of Transcription-3 (STAT3) Activation
por: Zhang, Geng, et al.
Publicado: (2019)

Silence of TANK-binding kinase 1 (TBK1) regulates extracellular matrix degradation of chondrocyte in osteoarthritis by janus kinase (JAK)-signal transducer of activators of transcription (STAT) signaling
por: Sun, Peng, et al.
Publicado: (2022)

Oral Janus kinase inhibitors in the treatment of atopic dermatitis: A systematic review and meta‐analysis
por: Lee, Kevin P., et al.
Publicado: (2022)

Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib
por: Caudrelier, Nicolas, et al.
Publicado: (2023)

Dr. Adams, on the Slough
por: Adams, Joseph
Publicado: (1805)

Observations on Sloughing Sores
por: Babington, G. G.
Publicado: (1827)

Case of Sloughing Hernia
por: Watson, Patrick Heron
Publicado: (1870)

Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
por: Kiely, Lisa, et al.
Publicado: (2022)

Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence
por: Kamata, Masahiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r3t2aa2ipq78k9qt1acpgq5sqt